Integrated Annual Report 2015
Please choose your report version
Net sales
Results
Cashflow
Share
Investments/​R&D expenditures
Currency effects

Net sales +2.7% Organic, currency-adjusted net sales growth in 2015

Chart is loading ...
Chart is loading ...
1 Adjusted for costs in connection with the Sanitec acquisition (transaction, integration, and one-off financing costs, as well as the amortisation of intangible assets and one-off costs resulting from the inventory revaluation)
Chart is loading ...
1 Adjusted for costs in connection with the Sanitec acquisition (transaction, integration, and one-off financing costs, as well as the amortisation of intangible assets and one-off costs resulting from the inventory revaluation)

Operating cashflow margin2
(EBITDA margin) 26.7%

2 Adjusted for costs in connection with the Sanitec acquisition (transaction, integration, as well as one-off costs resulting from the inventory revaluation)

Free Cashflow
(in CHF) 484.0 mio. 5.1% above prior year

Earnings per share1
(in CHF) 13.23 -0.4% versus prior year


1 Adjusted for costs in connection with the Sanitec acquisition (transaction, integration, and one-off financing costs, as well as the amortisation of intangible assets and one-off costs resulting from the inventory revaluation)

Payout ratio

63.3% The payout ratio is in the upper range of the target corridor of 50 to 70%

Investments in property, plant and equipment and intangible assets
(in CHF) 147.3 mio. +40.6% versus prior year

R&D expenditures
(in CHF)

63.4 mio. 7.6 million more versus prior year

Net sales
(in CHF) ≈ 200 mio. negative currency effects

Operating cashflow (EBITDA)
(in CHF) ≈ 70 mio. negative currency effects